Smoking Status and Metabolic Syndrome in the Multi-Ethnic Study of Atherosclerosis. A cross-sectional study
Current smoking is associated with type 2 diabetes mellitus and impaired glucose tolerance but its association with the metabolic syndrome (metS), particularly with sufficiently sampled African American representation, has not been clearly established.
To assess whether a) metS is associated with smoking; b) any increased risk of metS among smokers is independent of body mass index (BMI) compared with non-smokers; c) smoking status is differentially associated with the metS and its components across different ethnic groups.
Cross sectional analysis of the Multi-Ethnic Study of Atherosclerosis (MESA) a community population-based sample free of cardiovascular disease.
Current smokers (N = 769) had higher risk of metS (odds ratio [OR, 95% confidence interval]: 1.4, 1.1-1.7) versus never (reference, N = 2981) and former smokers (1.0, 0.8-1.1, N = 2163) and for metS components: high waist circumference (WC) (OR:1.9, 1.2-2.1), low high density lipoprotein cholesterol (HDL-C) (1.5, 1.3-1.8), elevated plasma triglycerides (TG) (OR:1.4, 1.2-1.7) as well as high C-reactive protein (CRP, an inflammatory marker) concentration (OR: 1.6,1.3-2.0) compared to never and former smokers after adjustment for BMI. A smoking status by ethnicity interaction occurred such that African American current and former smokers had greater likelihood of low HDL-C than White counterparts.
This study found that smoking is associated with the metS and despite the lower BMI of current smokers the prevalence of low HDL-C, elevated TG and CRP is higher among them than among non-smokers. African Americans generally have higher HDL-C than Whites but smoking wipes out this advantage.
Multi-Ethnic Study of Atherosclerosis (MESA) ClinicalTrials.gov Identifier: NCT00005487
- WHO Report on the Global Tobacco Epidemic: Warning about the dangers of tobacco. 2012. http://whqlibdoc.who.int/hq/2011/WHO_NMH_TFI_11.3_eng.pdf. Accessed on Jan 19, 2012
- Center for Disease Control: Smoking & Tobacco Use - Tobacco related mortality. 2012. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/tobacco_related_mortality/Accessed on Jan 19, 2012
- Ezzati M, Lopez AD: Estimates of global mortality attributable to smoking in 2000. Lancet 2003,362(9387):847–852. CrossRef
- Critchley J, Capewell S: Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004, 1:CD003041.
- Berlin I: Smoking-induced metabolic disorders: a review. Diabetes Metab 2008, 34:307–314. CrossRef
- Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J: Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007, 298:2654–2664. CrossRef
- Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL: Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med 2010, 152:10–17.
- Luo J, Rossouw J, Tong E, Giovino GA, Lee C, Chen C, Ockene JK, Qi L, Margolis KL: Smoking cessation, weight gain, and risk of type 2 diabetes mellitus among postmenopausal women. Arch Intern Med 2012, 172:438–440. CrossRef
- Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI: Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ 2006, 332:1064–1069. CrossRef
- Kowall B, Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, Giani G, Peters A, Meisinger C: Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol 2010, 25:393–402. CrossRef
- Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989, 298:784–788. CrossRef
- Bakhru A, Erlinger TP: Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005,2(6):e160. CrossRef
- Rouvre M, Vol S, Gusto G, et al.: Low high density lipoprotein cholesterol: prevalence and associated risk-factors in a large French population. Ann Epidemiol 2010, 21:118–127. CrossRef
- Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U: Smoking induces insulin resistance–a potential link with the insulin resistance syndrome. J Intern Med 1993, 233:327–332. CrossRef
- Reaven G, Tsao PS: Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003, 41:1044–1047. CrossRef
- Borissova AM, Tankova T, Kirilov G, Dakovska L, Krivoshiev S: The effect of smoking on peripheral insulin sensitivity and plasma endothelin level. Diabetes Metab 2004, 30:147–152. CrossRef
- Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK: Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003, 138:891–897.
- Tonstad S, Cowan JL: C-reactive protein as a predictor of disease in smokers and former smokers: a review. Int J Clin Pract 2009, 63:1634–1641. CrossRef
- Zhu S, St-Onge MP, Heshka S, Heymsfield SB: Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism 2004, 53:1503–1511. CrossRef
- Lee WY, Jung CH, Park JS, Rhee EJ, Kim SW: Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract 2005, 67:70–77. CrossRef
- Katano S, Nakamura Y, Nakamura A, et al.: Relationship among physical activity, smoking, drinking and clustering of the metabolic syndrome diagnostic components. J Atheroscler Thromb 2010, 17:644–650. CrossRef
- Geslain-Biquez C, Vol S, Tichet J, Caradec A, D'Hour A, Balkau B: The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab 2003, 29:226–234. CrossRef
- Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K: Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985–2001. Diabetes Care 2004, 27:2707–2715. CrossRef
- Onat A, Ozhan H, Esen AM, et al.: Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women–without associated overall health benefit. Atherosclerosis 2007, 193:380–388. CrossRef
- Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T: Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991, 324:739–745. CrossRef
- Shimokata H, Muller DC, Andres R: Studies in the distribution of body fat III. Effects of cigarette smoking. JAMA 1989, 261:1169–1173. CrossRef
- Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S: Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health 1997, 51:252–260. CrossRef
- Albanes D, Jones DY, Micozzi MS, Mattson ME: Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 1987, 77:439–444. CrossRef
- Chiolero A, Faeh D, Paccaud F, Cornuz J: Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008, 87:801–809.
- Canoy D, Wareham N, Luben R, et al.: Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res 2005, 13:1466–1475. CrossRef
- Bamia C, Trichopoulou A, Lenas D, Trichopoulos D: Tobacco smoking in relation to body fat mass and distribution in a general population sample. Int J Obes Relat Metab Disord 2004, 28:1091–1096. CrossRef
- The Emerging Risk Factors Collaboration: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant metaanalysis Lancet 2010, 375:132–140.
- Bild DE, Bluemke DA, Burke GL, et al.: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156:871–881. CrossRef
- Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004, 24:e13-e18. CrossRef
- Alberti KG, Zimmet P, Shaw J: Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469–480. CrossRef
- Bertoni AG, Burke GL, Owusu JA, et al.: Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2010, 33:804–810. CrossRef
- Bahrami H, Bluemke DA, Kronmal R, et al.: Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 2008, 51:1775–1783. CrossRef
- Ainsworth BE, Haskell WL, Whitt MC, et al.: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:S498-S504. CrossRef
- Bertoni AG, Whitt-Glover MC, Chung H, et al.: The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2009, 169:444–454. CrossRef
- Fiore MC, Baker TB: Treating smokers in the health care setting. N Engl J Med 2011, 365:1222–1231. CrossRef
- Leone A: Does smoking act as a friend or enemy of blood pressure? Let release Pandora's box. Cardiol Res Pract 2011., 264894:
- Barnaards CM, Twisk JWR, Snel J, van Mechelen W, Kemper HCG: In a prospective study in young people, associations between changes in smoking behavior and risk for cardiovascular dieseas were complex. J Clin Epidemiol 2005, 58:1165–1171. CrossRef
- Teshima K, Imamura H, Uchida K, Miyamoto N, Masuda Y, Kobata D: Cigarette smoking, blood pressure and serum lipids in Japanese men aged 20–39 years. J Physiol Anthropol Appl Human Sci 2001, 20:43–45. CrossRef
- Imamura H, Teshima K, Miyamoto N, Shirota T: Cigarette smoking, high-density lipoprotein cholesterol subfractions, and lecithin: cholesterol acyltransferase in young women. Metabolism 2002, 51:1313–1316. CrossRef
- Henkin L, Zaccaro D, Haffner S, Karter A, Rewers M, Sholinsky P, Wagenknecht L: Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity. Ann Epidemiol 1999, 9:290–296. CrossRef
- Lin SX, Carnethon M, Szklo M, Bertoni A: Racial/ethnic differences in the association of triglycerides with other metabolic syndrome components: the Multi-Ethnic Study of Atherosclerosis. Metab Syndr Relat Disord 2010, 9:35–40. CrossRef
- Metcalf PA, Sharrett AR, Folsom AR, et al.: African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1998, 148:750–760. CrossRef
- Cowie CC, Howard BV, Harris MI: Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population. Circulation 1994, 90:1185–1193. CrossRef
- Morrison JA, Khoury P, Mellies M, Kelly K, Horvitz R, Glueck CJ: Lipid and lipoprotein distributions in black adults. The Cincinnati Lipid Research Clinic's Princeton School Study. JAMA 1981, 245:939–942. CrossRef
- Carnethon MR, Palaniappan LP, Burchfiel CM, Brancati FL, Fortmann SP: Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987–1998. Diabetes Care 2002, 25:1358–1364. CrossRef
- Fulkerson JA, French SA: Cigarette smoking for weight loss or control among adolescents : Gender and racial/ethnic differences. J Adolesc Health 2003, 32:306–313. CrossRef
- Clark MM, Decker PA, Offord KP, Patten CA, Vickers KS, Croghan IT, Taylor-Hays T, Hurt RD, Dale LC: Weight concerns among male smokers. Addictive Behaviors 2004, 29:1637–1641. CrossRef
- Pisinger C, Jorgensen T: Weight concerns and smoking in a general population: the Inter99 study. Preventive Medicine 2007, 44:296–297. CrossRef
- Pomerleau CS, Zucker AN, Stewart AJ: Characterizing concerns about post-cessation weight gain: results from a national survey of women smokers. Nicotine Tob Res 2001, 3:51–60. CrossRef
- Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H: The impact of body weight on smoking cessation in German adults. Preventive Medicine 2006, 42:109–113. CrossRef
- Clair C, Berlin I, Cornuz J: Tabagisme, obésité et diabète : une interaction cliniquement importante. Rev Med Suisse 2011, 7:2338–2342.
- Smoking Status and Metabolic Syndrome in the Multi-Ethnic Study of Atherosclerosis. A cross-sectional study
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Tobacco Induced Diseases
- Online Date
- June 2012
- Online ISSN
- BioMed Central
- Additional Links
- Metabolic syndrome
- Ethnic groups
- Body mass index
- Author Affiliations
- 1. Hôpital Pitié-Salpêtrière, Assistance publique-Hôpitaux de Paris, Université P. & M. Curie, Faculté de médecine, INSERM 894, Paris, France
- 2. Center for Family and Community Medicine, Columbia University, New York, NY, USA
- 3. Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 4. Wake Forest University School of Medicine, Winston-Salem, NC, USA